559 related articles for article (PubMed ID: 12770562)
21. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
22. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
Schlosburg JE; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):314-23. PubMed ID: 19168707
[TBL] [Abstract][Full Text] [Related]
23. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
25. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity.
Hill MN; Barr AM; Ho WS; Carrier EJ; Gorzalka BB; Hillard CJ
J Neurochem; 2007 Oct; 103(1):47-56. PubMed ID: 17561935
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
27. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
28. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
Bátkai S; Rajesh M; Mukhopadhyay P; Haskó G; Liaudet L; Cravatt BF; Csiszár A; Ungvári Z; Pacher P
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H909-18. PubMed ID: 17434980
[TBL] [Abstract][Full Text] [Related]
29. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.
Patel S; Wohlfeil ER; Rademacher DJ; Carrier EJ; Perry LJ; Kundu A; Falck JR; Nithipatikom K; Campbell WB; Hillard CJ
Br J Pharmacol; 2003 Jul; 139(5):1005-13. PubMed ID: 12839875
[TBL] [Abstract][Full Text] [Related]
30. Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury.
Lever IJ; Robinson M; Cibelli M; Paule C; Santha P; Yee L; Hunt SP; Cravatt BF; Elphick MR; Nagy I; Rice AS
J Neurosci; 2009 Mar; 29(12):3766-80. PubMed ID: 19321773
[TBL] [Abstract][Full Text] [Related]
31. Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats.
Strittmatter F; Gandaglia G; Benigni F; Bettiga A; Rigatti P; Montorsi F; Gratzke C; Stief C; Colciago G; Hedlund P
Eur Urol; 2012 Jan; 61(1):98-106. PubMed ID: 21930339
[TBL] [Abstract][Full Text] [Related]
32. The fatty acid amide hydrolase (FAAH).
Deutsch DG; Ueda N; Yamamoto S
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):201-10. PubMed ID: 12052036
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
[TBL] [Abstract][Full Text] [Related]
34. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.
Bowles NP; Hill MN; Bhagat SM; Karatsoreos IN; Hillard CJ; McEwen BS
Neuroscience; 2012 Mar; 204():83-9. PubMed ID: 21939741
[TBL] [Abstract][Full Text] [Related]
35. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons.
Harkany T; Härtig W; Berghuis P; Dobszay MB; Zilberter Y; Edwards RH; Mackie K; Ernfors P
Eur J Neurosci; 2003 Oct; 18(7):1979-92. PubMed ID: 14622230
[TBL] [Abstract][Full Text] [Related]
36. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
37. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.
Maione S; Morera E; Marabese I; Ligresti A; Luongo L; Ortar G; Di Marzo V
Br J Pharmacol; 2008 Nov; 155(5):775-82. PubMed ID: 18660824
[TBL] [Abstract][Full Text] [Related]
40. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.
Maccarrone M; Valverde O; Barbaccia ML; Castañé A; Maldonado R; Ledent C; Parmentier M; Finazzi-Agrò A
Eur J Neurosci; 2002 Apr; 15(7):1178-86. PubMed ID: 11982628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
